WHAT IS ISBT 128?
WHO USES ISBT 128?
A Unifying Standard
Approved by the ISBT Council in 1994, the ISBT 128 Standard has gained international acceptance. Its use for Cellular Therapy products is supported by the boards of the AABB, ASFA, ASBMT, EBMT, FACT, ISBT, ISCT, ISCT Europe, JACIE, NMDP, and WMDA.
Facilities across six continents are registered to use ISBT 128. There are over 5,700 active registered facilities worldwide.
COUNTRIES WITH ACTIVE REGISTERED FACILITIES
Egypt, Arab Rep.
Iran, Islamic Rep.
Syrian Arab Republic
United Arab Emirates
If your country is not listed, please notify us.
ISBT 128 USER EXPERIENCE
"In addition to being beneficial for donors, patients, and safety, ISBT 128 has been very beneficial for the vendors of IT systems. It enables several IT systems to coexist in a country or a region, since all exchanged blood products are uniformly labeled and carry all relevant information. ISBT 128 reduces vendors' cost since we can focus on one standard when implementing the business logic for products and bedside control. We anticipate future standards for interfacing production equipment."